Skip to main content
Premium Trial:

Request an Annual Quote

Seeking Nasdaq Listing, WaferGen Effects One-for-10 Reverse Stock Split

NEW YORK (GenomeWeb) – WaferGen Biosystems said after the close of the market on Monday that it has effected a one-for-10 reverse stock split as it seeks to list its shares on the Nasdaq Capital Market.

The company's shares will start trading on a split adjusted basis on the OTCBB when the markets open on July 1. The shares will trade for 20 days under the temporary trading symbol "WGBSD." The "D" indicates that the reverse stock split has occurred.

As a result of the reverse stock split, the number of WaferGen's issued and outstanding shares will contract to about 930,000 shares from 9.3 million shares. Earlier this month, the Fremont, Calif.-based firm disclosed its intentions to move to the Nasdaq following a $40 million public offering of its common stock.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.